Jefferies Resumes Cabaletta Bio Inc. (CABA) at Buy

Jefferies analyst Roger Song resumes coverage on Cabaletta Bio Inc. (NASDAQ: CABA) with a Buy rating and a price target of $14.00.

The analyst comments "We caught up with mgmt. Co reported 3 pts data from rese-cel substudy of RESET-PV at ESGCT. Although not the main program, data is promising/ provides POC for rese-cel in AID setting w/o preconditioning, with broad impact/ readthrough to Co's core franchise - IIM/ SLE/ SSc/ gMG. We discuss the implications from this data and continue to look forward to major updates from Ph1/2 basket study at ACR. Coverage is transferred to Roger Song."

For an analyst ratings summary and ratings history on Cabaletta Bio Inc. click here. For more ratings news on Cabaletta Bio Inc. click here.

Shares of Cabaletta Bio Inc. closed at $2.85 yesterday.

You May Also Be Interested In